Showing results (111-120 of 398) with videos related to

Sort By:
Pageof 40
Frontiers in Oncology|June 18, 2024
Avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma: real-world results from a Korean expanded access programSe Hoon Park, Sang Joon Shin, Sun Young Rha, et al.
Cancer Research and Treatment|February 13, 2014
Chemotherapy in advanced gastric cancer patients associated with disseminated intravascular coagulationIn Gyu Hwang, Jin Hwa Choi, Se Hoon Park, et al.
Oncology|August 28, 2004
First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancerSe Hoon Park, Soo-Mee Bang, Eun Kyung Cho, et al.
Asia-Pacific Journal of Clinical Oncology|April 1, 2016
Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinomaSung Hee Lim, In Gyu Hwang, Jun Ho Ji, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 29, 2008
Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapySe Hoon Park, Moon Sook Cho, Young Saing Kim, et al.
Translational Oncology|May 15, 2017
Antitumor Effect of AZD4547 in a Fibroblast Growth Factor Receptor 2-Amplified Gastric Cancer Patient-Derived Cell ModelJiryeon Jang, Hee Kyung Kim, Heejin Bang, et al.
Targeted Oncology|February 29, 2020
Use of Gefitinib in EGFR-Amplified Refractory Solid Tumors: An Open-Label, Single-Arm, Single-Center Prospective Pilot StudySeonggyu Byeon, Jung Yong Hong, Jeeyun Lee, et al.
Therapeutic Advances in Medical Oncology|March 15, 2021
Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumorsHana Kim, Jung Yong Hong, Jeeyun Lee, et al.
ESMO Open|November 16, 2016
NanoString expression profiling identifies candidate biomarkers of RAD001 response in metastatic gastric cancerKakoli Das, Xiu Bin Chan, David Epstein, et al.
Cancer Research and Treatment|September 23, 2009
A pilot study of cisplatin, irinotecan, leucovorin and 5-fluorouracil (PILF) combination chemotherapy for advanced gastric cancerSe Hoon Park, Soo Yeon Jeon, Kwang Il Ko, et al.
Pageof 40